Levofloxacin hydrate
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Description: Levofloxacin hydrate (Cravit hydrate) is a broad-spectrum, third-generation... more
Product information "Levofloxacin hydrate"
Description: Levofloxacin hydrate (Cravit hydrate) is a broad-spectrum, third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity. Levofloxacin diffuses through the bacterial cell wall and acts by inhibiting DNA gyrase (bacterial topoisomerase II), an enzyme required for DNA replication, RNA transcription, and repair of bacterial DNA. Inhibition of DNA gyrase activity leads to blockage of bacterial cell growth. Target: Antibacterial, Antibiotic, Topoisomerase, DNA gyrase. Smiles: O.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O. References: Schmitz FJ, et al. J Antimicrob ChemOthers. 1998 Apr,41(4):481-4.
| Keywords: | Iquix hydrate, Tavanic hydrate, Levofloxacin Hemihydrate, Quixin hydrate, Cravit hydrate, Levaquin hydrate |
| Supplier: | TargetMol |
| Supplier-Nr: | T1451 |
Properties
| Application: | Antibacterial, Nucleic acid biosynthesis inhibitor |
| MW: | 370.38 D |
| Formula: | C18H20FN3O4·1/2H2O |
Database Information
| CAS : | 138199-71-0| Matching products |
Handling & Safety
| Storage: | +4°C |
| Shipping: | +4°C (International: +4°C) |
| Signal Word: | Danger |
| GHS Hazard Pictograms: |
|
| H Phrases: | H302, H317, H334, H361, H362 |
| P Phrases: | P201, P202, P260, P261, P263, P264, P270, P272, P280, P284, P321, P330, P301+P310, P302+P352, P304+P341, P308+P313, P333+P313, P342+P311, P362+P364, P405, P501 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
Viewed